UniProt ID | TYK2_HUMAN | |
---|---|---|
UniProt AC | P29597 | |
Protein Name | Non-receptor tyrosine-protein kinase TYK2 | |
Gene Name | TYK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1187 | |
Subcellular Localization | ||
Protein Description | Probably involved in intracellular signal transduction by being involved in the initiation of type I IFN signaling. Phosphorylates the interferon-alpha/beta receptor alpha chain.. | |
Protein Sequence | MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
67 | Phosphorylation | IAHKVGITPPCFNLF HHHHCCCCCCCCCHH | 18.43 | - | |
123 | Phosphorylation | NPREPAVYRCGPPGT CCCCCCEEECCCCCC | 11.42 | 30576142 | |
207 | Ubiquitination | IPLEEVAKKTSFKDC CCHHHHHHHCCHHHH | 62.86 | - | |
208 | Ubiquitination | PLEEVAKKTSFKDCI CHHHHHHHCCHHHHC | 39.40 | - | |
218 | Phosphorylation | FKDCIPRSFRRHIRQ HHHHCCHHHHHHHHH | 20.11 | 27067055 | |
259 | Phosphorylation | QQMVMVKYLATLERL HHHHHHHHHHHHHHH | 7.08 | 26503514 | |
262 | Phosphorylation | VMVKYLATLERLAPR HHHHHHHHHHHHHHH | 26.93 | 26503514 | |
292 | Phosphorylation | QAEGEPCYIRDSGVA HCCCCCCEEECCCCC | 15.09 | 22322096 | |
296 | Phosphorylation | EPCYIRDSGVAPTDP CCCEEECCCCCCCCC | 25.89 | 26074081 | |
301 | Phosphorylation | RDSGVAPTDPGPESA ECCCCCCCCCCCCCC | 45.12 | 26074081 | |
339 | Phosphorylation | EVNKEEGSSGSSGRN CCCCCCCCCCCCCCC | 34.50 | - | |
340 | Phosphorylation | VNKEEGSSGSSGRNP CCCCCCCCCCCCCCC | 54.26 | - | |
354 | Ubiquitination | PQASLFGKKAKAHKA CCHHHHCHHHHHHHH | 42.07 | - | |
355 | Ubiquitination | QASLFGKKAKAHKAV CHHHHCHHHHHHHHC | 56.34 | - | |
389 | Ubiquitination | DITHVVLKEHCVSIH CCCCHHHHHHHEEEE | 33.53 | - | |
401 | Ubiquitination | SIHRQDNKCLELSLP EEECCCCCEEEECCC | 48.78 | - | |
406 | Phosphorylation | DNKCLELSLPSRAAA CCCEEEECCCCHHHH | 28.94 | 28348404 | |
415 | Phosphorylation | PSRAAALSFVSLVDG CCHHHHHHHHHHHCC | 20.90 | 28348404 | |
418 | Phosphorylation | AAALSFVSLVDGYFR HHHHHHHHHHCCEEE | 22.21 | 24719451 | |
423 | Phosphorylation | FVSLVDGYFRLTADS HHHHHCCEEEECCCC | 4.89 | 27251275 | |
427 | Phosphorylation | VDGYFRLTADSSHYL HCCEEEECCCCCCEE | 24.94 | 28152594 | |
430 | Phosphorylation | YFRLTADSSHYLCHE EEEECCCCCCEEECC | 19.29 | 28152594 | |
431 | Phosphorylation | FRLTADSSHYLCHEV EEECCCCCCEEECCC | 19.39 | 28152594 | |
433 | Phosphorylation | LTADSSHYLCHEVAP ECCCCCCEEECCCCC | 16.99 | 20090780 | |
471 | Phosphorylation | LRPEDGLYLIHWSTS ECCCCCEEEEEECCC | 14.78 | 26552605 | |
476 | Phosphorylation | GLYLIHWSTSHPYRL CEEEEEECCCCCCEE | 13.08 | 26552605 | |
477 | Phosphorylation | LYLIHWSTSHPYRLI EEEEEECCCCCCEEE | 26.34 | 26552605 | |
478 | Phosphorylation | YLIHWSTSHPYRLIL EEEEECCCCCCEEEE | 19.56 | 26552605 | |
481 | Phosphorylation | HWSTSHPYRLILTVA EECCCCCCEEEEEHH | 16.78 | 26552605 | |
486 | Phosphorylation | HPYRLILTVAQRSQA CCCEEEEEHHHHHCC | 13.55 | 26552605 | |
491 | Phosphorylation | ILTVAQRSQAPDGMQ EEEHHHHHCCCCCCC | 20.72 | 26552605 | |
499 | Phosphorylation | QAPDGMQSLRLRKFP CCCCCCCCCEEEECC | 13.43 | 21082442 | |
504 | Ubiquitination | MQSLRLRKFPIEQQD CCCCEEEECCCCCCC | 61.15 | - | |
525 | Phosphorylation | GWGRSFPSVRELGAA CCCCCCCCHHHHHHH | 31.62 | - | |
577 | Phosphorylation | SPRTLNLSQLSFHRV CCCCCCHHHHCCEEC | 28.18 | 28450419 | |
580 | Phosphorylation | TLNLSQLSFHRVDQK CCCHHHHCCEECCHH | 16.03 | 28450419 | |
587 | Ubiquitination | SFHRVDQKEITQLSH CCEECCHHHHHHHHH | 46.77 | - | |
604 | Phosphorylation | QGTRTNVYEGRLRVE CCCCCCEEEEEEEEE | 18.09 | - | |
613 | Phosphorylation | GRLRVEGSGDPEEGK EEEEEECCCCCCCCC | 26.90 | 26657352 | |
720 | Phosphorylation | VVAQQLASALSYLEN HHHHHHHHHHHHHHC | 38.03 | - | |
723 | Phosphorylation | QQLASALSYLENKNL HHHHHHHHHHHCCCC | 27.64 | - | |
728 | Ubiquitination | ALSYLENKNLVHGNV HHHHHHCCCCCCCCC | 42.13 | - | |
756 | Ubiquitination | EGTSPFIKLSDPGVG CCCCCCEECCCCCCC | 42.17 | 21906983 | |
823 | Ubiquitination | QSRSPSEKEHFYQRQ CCCCHHHHHHHHHHH | 61.91 | - | |
827 | Phosphorylation | PSEKEHFYQRQHRLP HHHHHHHHHHHHCCC | 12.51 | 25884760 | |
851 | Phosphorylation | LTSQCLTYEPTQRPS HHHHHCCCCCCCCCC | 13.63 | 27642862 | |
879 | Phosphorylation | HNLADVLTVNPDSPA CCCCCCEEECCCCCC | 20.34 | 26657352 | |
884 | Phosphorylation | VLTVNPDSPASDPTV CEEECCCCCCCCCCH | 24.51 | 22617229 | |
887 | Phosphorylation | VNPDSPASDPTVFHK ECCCCCCCCCCHHHH | 47.72 | 30108239 | |
890 | Phosphorylation | DSPASDPTVFHKRYL CCCCCCCCHHHHHHH | 40.57 | 29523821 | |
899 | Ubiquitination | FHKRYLKKIRDLGEG HHHHHHHHHHHHCCC | 40.14 | - | |
912 | Phosphorylation | EGHFGKVSLYCYDPT CCCCCEEEEEEECCC | 19.67 | 23663014 | |
914 | Phosphorylation | HFGKVSLYCYDPTND CCCEEEEEEECCCCC | 4.97 | 23663014 | |
916 | Phosphorylation | GKVSLYCYDPTNDGT CEEEEEEECCCCCCC | 16.05 | 23663014 | |
919 | Phosphorylation | SLYCYDPTNDGTGEM EEEEECCCCCCCCCE | 42.94 | 23663014 | |
923 | Phosphorylation | YDPTNDGTGEMVAVK ECCCCCCCCCEEEEE | 32.60 | 23663014 | |
930 | Ubiquitination | TGEMVAVKALKADCG CCCEEEEEEEECCCC | 37.96 | - | |
933 | Ubiquitination | MVAVKALKADCGPQH EEEEEEEECCCCCCC | 47.22 | - | |
945 | Ubiquitination | PQHRSGWKQEIDILR CCCCCCHHHHHHHHH | 41.39 | - | |
963 | Ubiquitination | HEHIIKYKGCCEDQG HHHHHHCCCCCCCCC | 40.23 | - | |
985 | Phosphorylation | MEYVPLGSLRDYLPR HHHCCCCHHHHHCHH | 28.10 | 24719451 | |
1046 | Ubiquitination | IGDFGLAKAVPEGHE ECCCCCEECCCCCCC | 55.76 | - | |
1054 | Phosphorylation | AVPEGHEYYRVREDG CCCCCCCEEEECCCC | 7.30 | 25159151 | |
1055 | Phosphorylation | VPEGHEYYRVREDGD CCCCCCEEEECCCCC | 10.31 | 28796482 | |
1074 | Ubiquitination | WYAPECLKEYKFYYA EECHHHHHHCCEEEH | 71.32 | - | |
1145 | Phosphorylation | DKCPCEVYHLMKNCW CCCCHHHHHHHHHHH | 2.71 | 22817900 | |
1175 | Ubiquitination | ILKTVHEKYQGQAPS HHHHHHHHHCCCCCC | 28.17 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
292 | Y | Phosphorylation | Kinase | TYK2 | P29597 | PSP |
1054 | Y | Phosphorylation | Kinase | JAK1 | P23458 | PhosphoELM |
1054 | Y | Phosphorylation | Kinase | TYK2 | P29597 | PSP |
1055 | Y | Phosphorylation | Kinase | JAK1 | P23458 | PhosphoELM |
1055 | Y | Phosphorylation | Kinase | TYK2 | P29597 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TYK2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TYK2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
611521 | Immunodeficiency 35 (IMD35) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292; SER-499 ANDSER-884, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292; SER-499 ANDSER-884, AND MASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-292, AND MASSSPECTROMETRY. |